Raman Spectroscopy: An Emerging Tool in Neurodegenerative Disease Research and Diagnosis.

The pathogenesis underlining many neurodegenerative diseases remains incompletely understood. The lack of effective biomarkers and disease preventative medicine demands the development of new techniques to efficiently probe the mechanisms of disease and to detect early biomarkers predictive of disease onset. Raman spectroscopy is an established technique that allows the label-free fingerprinting and imaging of molecules based on their chemical constitution and structure. While analysis of isolated biological molecules has been widespread in the chemical community, applications of Raman spectroscopy to study clinically relevant biological species, disease pathogenesis, and diagnosis have been rapidly increasing since the past decade. The growing number of biomedical applications has shown the potential of Raman spectroscopy for detection of novel biomarkers that could enable the rapid and accurate screening of disease susceptibility and onset. Here we provide an overview of Raman spectroscopy and related techniques and their application to neurodegenerative diseases. We further discuss their potential utility in research, biomarker detection, and diagnosis. Challenges to routine use of Raman spectroscopy in the context of neuroscience research are also presented.

[1]  H. Beier,et al.  Nanofluidic biosensing for beta-amyloid detection using surface enhanced Raman spectroscopy. , 2008, Nano letters.

[2]  John K. J. Archer,et al.  Near infrared Raman spectroscopy for Alzheimer's disease detection , 2005, European Conference on Biomedical Optics.

[3]  H. Beier,et al.  Application of Surface-Enhanced Raman Spectroscopy for Detection of Beta Amyloid Using Nanoshells , 2007 .

[4]  S. S. Sinha,et al.  Hybrid Graphene Oxide Based Plasmonic-Magnetic Multifunctional Nanoplatform for Selective Separation and Label-Free Identification of Alzheimer's Disease Biomarkers. , 2015, ACS applied materials & interfaces.

[5]  I. Lednev,et al.  Raman spectroscopy of blood serum for Alzheimer's disease diagnostics: specificity relative to other types of dementia , 2015, Journal of biophotonics.

[6]  R. Dasari,et al.  Ultrasensitive Chemical Analysis by Raman Spectroscopy , 1999 .

[7]  C. Cowan,et al.  Rescue from tau-induced neuronal dysfunction produces insoluble tau oligomers , 2015, Scientific Reports.

[8]  R. Michael,et al.  Absence of beta-amyloid in cortical cataracts of donors with and without Alzheimer's disease. , 2012, Experimental eye research.

[9]  Meikun Fan,et al.  A review on the fabrication of substrates for surface enhanced Raman spectroscopy and their applications in analytical chemistry. , 2011, Analytica chimica acta.

[10]  R. Goodacre,et al.  The importance of protonation in the investigation of protein phosphorylation using Raman spectroscopy and Raman optical activity. , 2011, Analytical chemistry.

[11]  Charles H. Camp,et al.  High-Speed Coherent Raman Fingerprint Imaging of Biological Tissues , 2014, Nature Photonics.

[12]  H. P. Lu,et al.  Revealing the secondary structural changes of amyloid β peptide by probing the spectral fingerprint characters , 2013 .

[13]  P. Lansbury,et al.  NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. , 1996, Biochemistry.

[14]  Conor L Evans,et al.  Raman technologies in cancer diagnostics. , 2016, The Analyst.

[15]  R. Myers Huntington’s disease genetics , 2004, NeuroRX.

[16]  A. Shen,et al.  Raman signature from brain hippocampus could aid Alzheimer's disease diagnosis. , 2009, Applied optics.

[17]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[18]  H. Takeuchi,et al.  Metal‐dependent α‐helix formation promoted by the glycine‐rich octapeptide region of prion protein , 1996, FEBS letters.

[19]  Jeong-Woo Choi,et al.  Surface-enhanced Raman scattering of dopamine on self-assembled gold nanoparticles. , 2011, Journal of nanoscience and nanotechnology.

[20]  David I. Ellis,et al.  Illuminating disease and enlightening biomedicine: Raman spectroscopy as a diagnostic tool. , 2013, The Analyst.

[21]  Bappaditya Chandra,et al.  Cell-Membrane-Mimicking Lipid-Coated Nanoparticles Confer Raman Enhancement to Membrane Proteins and Reveal Membrane-Attached Amyloid-β Conformation. , 2015, ACS nano.

[22]  Ali Monfared,et al.  Detection of amino acid neurotransmitters by surface enhanced Raman scattering and hollow core photonic crystal fiber , 2012, Other Conferences.

[23]  E. Mandelkow,et al.  Tau in physiology and pathology , 2015, Nature Reviews Neuroscience.

[24]  G. Fisone,et al.  Understanding cognitive deficits in Parkinson's disease: lessons from preclinical animal models. , 2013, Learning & memory.

[25]  C. Cowan,et al.  Are Tau Aggregates Toxic or Protective in Tauopathies? , 2013, Front. Neurol..

[26]  B. Dietzek,et al.  Coherent anti-Stokes Raman scattering and two photon excited fluorescence for neurosurgery , 2015, Clinical Neurology and Neurosurgery.

[27]  G. Ricevuti,et al.  Alzheimer disease and platelets: how’s that relevant , 2012, Immunity & Ageing.

[28]  N. Maiti,et al.  Secondary structure of alpha-synuclein oligomers: characterization by raman and atomic force microscopy. , 2006, Journal of molecular biology.

[29]  Bernard Schneider,et al.  α-Synuclein in Central Nervous System and from Erythrocytes, Mammalian Cells, and Escherichia coli Exists Predominantly as Disordered Monomer* , 2012, The Journal of Biological Chemistry.

[30]  S. Lovestone,et al.  GSK-3β inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila , 2004, Molecular Psychiatry.

[31]  R. Lal,et al.  Amyloid β protein forms ion channels: implications for Alzheimer's disease pathophysiology , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  T. Creamer,et al.  Polyproline II helical structure in protein unfolded states: Lysine peptides revisited , 2002, Protein science : a publication of the Protein Society.

[33]  I. Prohovnik,et al.  Sensitivity and specificity of neuroimaging for the diagnosis of Alzheimer's disease , 2003, Dialogues in clinical neuroscience.

[34]  R. Burke,et al.  Clinical progression in Parkinson disease and the neurobiology of axons , 2010, Annals of neurology.

[35]  K. Hajian‐Tilaki,et al.  Receiver Operating Characteristic (ROC) Curve Analysis for Medical Diagnostic Test Evaluation. , 2013, Caspian journal of internal medicine.

[36]  W. Tolles,et al.  A Review of the Theory and Application of Coherent Anti-Stokes Raman Spectroscopy (CARS) , 1977 .

[37]  Jane S. Paulsen Cognitive Impairment in Huntington Disease: Diagnosis and Treatment , 2011, Current neurology and neuroscience reports.

[38]  S. Dey,et al.  Peroxidase to Cytochrome b Type Transition in the Active Site of Heme-Bound Amyloid β Peptides Relevant to Alzheimer's Disease. , 2016, Inorganic chemistry.

[39]  George Perry,et al.  Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence. , 2003, Biochemistry.

[40]  G. Thomas,et al.  Raman tensors and their application in structural studies of biological systems. , 2009, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

[41]  M. Luca,et al.  - Secretase ADAM 10 as Well as APPs Is Reduced in Platelets and CSF of Alzheimer Disease Patients , 2002 .

[42]  M. Luca,et al.  α-Secretase ADAM10 as Well as αAPPs Is Reduced in Platelets and CSF of Alzheimer Disease Patients , 2002, Molecular medicine.

[43]  I. Kang,et al.  Chitosan-gold Nano Composite for Dopamine Analysis using Raman Scattering , 2013 .

[44]  X. G. Chen,et al.  UV resonance Raman-selective amide vibrational enhancement: quantitative methodology for determining protein secondary structure. , 1998, Biochemistry.

[45]  Dae Hwan Kim,et al.  Label-free imaging and quantitative chemical analysis of Alzheimer’s disease brain samples with multimodal multiphoton nonlinear optical microspectroscopy , 2015, Journal of biomedical optics.

[46]  Ian Todd,et al.  ELISA in the multiplex era: Potentials and pitfalls , 2015, Proteomics. Clinical applications.

[47]  Thomas J. Paul,et al.  Structural and Mechanical Properties of Amyloid Beta Fibrils: A Combined Experimental and Theoretical Approach. , 2016, The journal of physical chemistry letters.

[48]  I. Kang,et al.  Fabrication of Chitosan-gold Nanocomposites Combined with Optical Fiber as SERS Substrates to Detect Dopamine Molecules , 2014 .

[49]  M. Sawaya,et al.  Structural Organization of Insulin Fibrils Based on Polarized Raman Spectroscopy: Evaluation of Existing Models. , 2015, Journal of the American Chemical Society.

[50]  K. S. Krishnan,et al.  A New Type of Secondary Radiation , 1928, Nature.

[51]  Lutz Hecht,et al.  Raman optical activity: a tool for protein structure analysis. , 2005, Structure.

[52]  K. Fukumitsu,et al.  NIR sensitivity enhancement by laser treatment for Si detectors , 2010 .

[53]  David Eisenberg,et al.  Atomic structures of amyloid cross-beta spines reveal varied steric zippers. , 2007, Nature.

[54]  Isaiah Norton,et al.  Label-Free Neurosurgical Pathology with Stimulated Raman Imaging. , 2016, Cancer research.

[55]  N. Maiti,et al.  Raman spectroscopic characterization of secondary structure in natively unfolded proteins: alpha-synuclein. , 2004, Journal of the American Chemical Society.

[56]  Laurence D. Barron,et al.  Rayleigh and Raman scattering from optically active molecules , 1971 .

[57]  S. Hovmöller,et al.  Conformations of amino acids in proteins. , 2002, Acta crystallographica. Section D, Biological crystallography.

[58]  Ronald Wetzel,et al.  Fluorescence correlation spectroscopy shows that monomeric polyglutamine molecules form collapsed structures in aqueous solutions , 2006, Proceedings of the National Academy of Sciences.

[59]  Alistair Elfick,et al.  Raman Spectroscopy and Related Techniques in Biomedicine , 2010, Sensors.

[60]  H. Banerjee,et al.  Intraoperative brain cancer detection with Raman spectroscopy in humans. , 2016, Annals of translational medicine.

[61]  R. Wetzel,et al.  Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity. , 2001, Journal of molecular biology.

[62]  E. Monleón,et al.  Raman analysis of prion protein in blood cell membranes from naturally affected scrapie sheep. , 2004, Chemistry & biology.

[63]  Ewan W Blanch,et al.  A Raman optical activity study of rheomorphism in caseins, synucleins and tau. New insight into the structure and behaviour of natively unfolded proteins. , 2002, European journal of biochemistry.

[64]  M. Vasák,et al.  Solution structure of native proteins with irregular folds from Raman optical activity. , 2001, Biopolymers.

[65]  C. Masters,et al.  Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease. , 2003, Lancet.

[66]  R. Jiji,et al.  Resolution of localized small molecule-Aβ interactions by deep-ultraviolet resonance Raman spectroscopy. , 2011, Biophysical chemistry.

[67]  S. Rivas-Arancibia,et al.  Structural Changes of Amyloid Beta in Hippocampus of Rats Exposed to Ozone: A Raman Spectroscopy Study , 2017, Front. Mol. Neurosci..

[68]  Hope T. Beier,et al.  A surface enhanced Raman spectroscopy platform based on nanoshells for detection of β-amyloid , 2008, SPIE BiOS.

[69]  P. Carmona,et al.  Vibrational spectroscopic analysis of peripheral blood plasma of patients with Alzheimer’s disease , 2015, Analytical and Bioanalytical Chemistry.

[70]  M. Maffia,et al.  Monitoring prion protein expression in complex biological samples by SERS for diagnostic applications , 2010, Nanotechnology.

[71]  S. Bykov,et al.  Peptide secondary structure folding reaction coordinate: correlation between uv raman amide III frequency, Psi Ramachandran angle, and hydrogen bonding. , 2006, The journal of physical chemistry. B.

[72]  P. Martínez-Martín,et al.  Discrimination analysis of blood plasma associated with Alzheimer's disease using vibrational spectroscopy. , 2013, Journal of Alzheimer's disease : JAD.

[73]  Regina M Murphy,et al.  Examining polyglutamine peptide length: a connection between collapsed conformations and increased aggregation. , 2009, Journal of molecular biology.

[74]  Camilo L. M. Morais,et al.  Differential diagnosis of Alzheimer’s disease using spectrochemical analysis of blood , 2017, Proceedings of the National Academy of Sciences.

[75]  Ming Xu,et al.  Dissecting structure of prion amyloid fibrils by hydrogen-deuterium exchange ultraviolet Raman spectroscopy. , 2012, The journal of physical chemistry. B.

[76]  Andreas Vitalis,et al.  Characterizing the conformational ensemble of monomeric polyglutamine , 2005, Proteins.

[77]  R. V. Van Duyne,et al.  Exploring the structure and formation mechanism of amyloid fibrils by Raman spectroscopy: a review. , 2015, The Analyst.

[78]  Herman L. Offerhaus,et al.  Polyglutamine Aggregate Structure In Vitro and In Vivo; New Avenues for Coherent Anti-Stokes Raman Scattering Microscopy , 2012, PloS one.

[79]  H. Anis,et al.  Surface-Enhanced Raman Scattering Spectroscopy for the Detection of Glutamate and $\gamma$-Aminobutyric Acid in Serum by Partial Least Squares Analysis , 2015, IEEE Photonics Journal.

[80]  Saulius Juodkazis,et al.  Statistically quantified measurement of an Alzheimer's marker by surface‐enhanced Raman scattering , 2015, Journal of biophotonics.

[81]  T. Creamer,et al.  Evidence for polyproline II helical structure in short polyglutamine tracts. , 2006, Journal of molecular biology.

[82]  M. Maffia,et al.  SERS based optical sensor to detect prion protein in neurodegenerate living cells , 2011 .

[83]  William J. Tipping,et al.  Stimulated Raman Scattering Microscopy: An Emerging Tool for Drug Discovery , 2016 .

[84]  M Muratore,et al.  Raman spectroscopy and partial least squares analysis in discrimination of peripheral cells affected by Huntington's disease. , 2013, Analytica chimica acta.

[85]  Nigel J. Cairns,et al.  Proteopathic tau seeding predicts tauopathy in vivo , 2014, Proceedings of the National Academy of Sciences.

[86]  A. Shen,et al.  Laser Raman detection of platelet as a non-invasive approach for early and differential diagnosis of Alzheimer's disease , 2011 .

[87]  C. Rowlands,et al.  Label-free molecular analysis of live Neospora caninum tachyzoites in host cells by selective scanning Raman micro-spectroscopy. , 2012, The Analyst.

[88]  M. Diamond,et al.  The prion model for progression and diversity of neurodegenerative diseases , 2017, The Lancet Neurology.

[89]  Francis L Martin,et al.  Extracting biological information with computational analysis of Fourier-transform infrared (FTIR) biospectroscopy datasets: current practices to future perspectives. , 2012, The Analyst.

[90]  Aufried T. M. Lenferink,et al.  Absence of amyloid-beta in lenses of Alzheimer patients: a confocal Raman microspectroscopic study. , 2014, Experimental eye research.

[91]  Abel Rodríguez,et al.  Early Onset Prion Disease from Octarepeat Expansion Correlates with Copper Binding Properties , 2009, PLoS pathogens.

[92]  Jeong-Woo Choi,et al.  Fabrication of gold nanoparticle modified ITO substrate to detect beta-amyloid using surface-enhanced Raman scattering. , 2011, Journal of nanoscience and nanotechnology.

[93]  Annalisa Pastore,et al.  Solution structure of polyglutamine tracts in GST‐polyglutamine fusion proteins , 2002, FEBS letters.

[94]  M. Goedert The ordered assembly of tau is the gain-of-toxic function that causes human tauopathies , 2016, Alzheimer's & Dementia.

[95]  G. Niaura,et al.  Surface-enhanced Raman spectroscopy for detection of toxic amyloid β oligomers adsorbed on self-assembled monolayers. , 2012, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[96]  Edmund Koch,et al.  Assessing the efficacy of coherent anti‐Stokes Raman scattering microscopy for the detection of infiltrating glioblastoma in fresh brain samples , 2017, Journal of biophotonics.

[97]  R. Venkatramani,et al.  pH changes the aggregation propensity of amyloid-β without altering the monomer conformation. , 2014, Physical chemistry chemical physics : PCCP.

[98]  Hidetoshi Sato,et al.  Raman endoscopy for the in situ investigation of advancing colorectal tumors in live model mice. , 2013, The Analyst.

[99]  H. Takeuchi,et al.  Copper reduction by the octapeptide repeat region of prion protein: pH dependence and implications in cellular copper uptake. , 2005, Biochemistry.

[100]  M. Goedert,et al.  Invited review: Prion‐like transmission and spreading of tau pathology , 2015, Neuropathology and applied neurobiology.

[101]  Rekha Gautam,et al.  Review of multidimensional data processing approaches for Raman and infrared spectroscopy , 2015, EPJ Techniques and Instrumentation.

[102]  S. Sánchez‐Cortés,et al.  Surface‐enhanced Raman spectroscopy of γ‐aminobutyric acid on silver colloid surfaces , 1997 .

[103]  D P Salmon,et al.  The Mini-Mental State Examination in the early diagnosis of Alzheimer's disease. , 1990, Archives of neurology.

[104]  R. Goodacre,et al.  Quantification of casein phosphorylation with conformational interpretation using Raman spectroscopy. , 2007, The Analyst.

[105]  U. Tamer,et al.  A SERS-based sandwich assay for ultrasensitive and selective detection of Alzheimer's tau protein. , 2013, Biomacromolecules.

[106]  M. Goedert,et al.  Propagation of Tau aggregates , 2017, Molecular Brain.

[107]  Hideo Takeuchi,et al.  Binding of iron(III) to the single tyrosine residue of amyloid β-peptide probed by Raman spectroscopy , 2001 .

[108]  Wei Min,et al.  Coherent nonlinear optical imaging: beyond fluorescence microscopy. , 2011, Annual review of physical chemistry.

[109]  O. Maes,et al.  Spectroscopy of human plasma for diagnosis of idiopathic Parkinson's disease. , 2008, Biomarkers in medicine.

[110]  S. Haswell,et al.  Metal imbalance and compromised antioxidant function are early changes in prion disease. , 2002, The Biochemical journal.

[111]  R. Jiji,et al.  Insights into the aggregation mechanism of Aβ(25-40). , 2017, Biophysical chemistry.

[112]  ScienceDirect,et al.  Nuclear instruments & methods in physics research. Section A, Accelerators, spectrometers, detectors and associated equipment , 1984 .

[113]  P E Wright,et al.  Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[114]  Jayant B Udgaonkar,et al.  Resonance Raman spectroscopic measurements delineate the structural changes that occur during tau fibril formation. , 2014, Biochemistry.

[115]  J. Pelton,et al.  Spectroscopic methods for analysis of protein secondary structure. , 2000, Analytical biochemistry.

[116]  Yang Yang,et al.  Copper Ion Binding Site in β-Amyloid Peptide. , 2016, Nano letters.

[117]  T. Spiro,et al.  Resonance Raman spectra of heme proteins. Effects of oxidation and spin state. , 1974, Journal of the American Chemical Society.

[118]  A. Kaczor,et al.  Raman spectroscopy of proteins: a review , 2013 .

[119]  Sanford A. Asher,et al.  UV resonance Raman studies of peptide conformation in poly(L-lysine), poly(L-glutamic acid), and model complexes: the basis for protein secondary structure determinations , 1989 .

[120]  K. Jeong,et al.  Nanoplasmonic biopatch for in vivo surface enhanced raman spectroscopy , 2014, BioChip Journal.

[121]  Christian Humpel,et al.  Identifying and validating biomarkers for Alzheimer's disease , 2011, Trends in biotechnology.

[122]  S. Asher,et al.  UV resonance Raman spectroscopy monitors polyglutamine backbone and side chain hydrogen bonding and fibrillization. , 2012, Biochemistry.

[123]  Ewan W Blanch,et al.  A new perspective on beta-sheet structures using vibrational Raman optical activity: from poly(L-lysine) to the prion protein. , 2003, Journal of the American Chemical Society.

[124]  V. Uversky Intrinsically disordered proteins and their (disordered) proteomes in neurodegenerative disorders , 2015, Front. Aging Neurosci..

[125]  P. Bouř,et al.  An Experimental Comparison of Vibrational Circular Dichroism and Raman Optical Activity with 1-Amino-2-propanol and 2-Amino-1-propanol as Model Compounds , 1997 .

[126]  J. Trojanowski,et al.  Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications. , 2006, Annual review of pathology.

[127]  L. Mucke,et al.  Alzheimer Mechanisms and Therapeutic Strategies , 2012, Cell.

[128]  Markus Tolnay,et al.  “Prion‐Like” Templated Misfolding in Tauopathies , 2013, Brain pathology.

[129]  M G Spillantini,et al.  Alpha-synuclein in Lewy bodies. , 1997, Nature.

[130]  Dustin W. Shipp,et al.  Raman spectroscopy: techniques and applications in the life sciences , 2017 .

[131]  J. Mcdermott,et al.  Copper binding to the N-terminal tandem repeat regions of mammalian and avian prion protein. , 1995, Biochemical and biophysical research communications.

[132]  A. Enejder,et al.  Plaque-associated lipids in Alzheimer’s diseased brain tissue visualized by nonlinear microscopy , 2015, Scientific Reports.

[133]  R. Martins,et al.  The involvement of lipids in Alzheimer's disease. , 2014, Journal of genetics and genomics = Yi chuan xue bao.

[134]  L. Grinberg,et al.  Distinct Tau Prion Strains Propagate in Cells and Mice and Define Different Tauopathies , 2014, Neuron.

[135]  S. Asher,et al.  Comparison between UV Raman and circular dichroism detection of short alpha helices in bombolitin III. , 2002, Biochemistry.

[136]  H. Takeuchi,et al.  Metal binding modes of Alzheimer's amyloid beta-peptide in insoluble aggregates and soluble complexes. , 2000, Biochemistry.

[137]  J. Koenig Raman spectroscopy of biological molecules: A review , 1972 .

[138]  J. Collinge,et al.  The cognitive profile of prion disease: a prospective clinical and imaging study , 2015, Annals of clinical and translational neurology.

[139]  D. Eliezer,et al.  Conformational properties of alpha-synuclein in its free and lipid-associated states. , 2001, Journal of molecular biology.

[140]  H. Takeuchi,et al.  Raman spectroscopic study on the copper(II) binding mode of prion octapeptide and its pH dependence. , 1999, Biochemistry.

[141]  R. Subramaniam,et al.  Brain PET in the Diagnosis of Alzheimer’s Disease , 2014, Clinical nuclear medicine.

[142]  C Caltagirone,et al.  Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease , 2004, Neurology.

[143]  Peter T. Lansbury,et al.  Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease , 1998, Nature Medicine.

[144]  K. Bötzel,et al.  Prevalence and incidence of Parkinson's disease in Europe , 2005, European Neuropsychopharmacology.

[145]  R. D'Hooge,et al.  Lipids revert inert Aβ amyloid fibrils to neurotoxic protofibrils that affect learning in mice , 2007, The EMBO Journal.

[146]  H. Kuroda Gamma-aminobutyric acid (GABA) in cerebrospinal fluid. , 1983, Acta medica Okayama.

[147]  F. Chiti,et al.  SERS Detection of Amyloid Oligomers on Metallorganic-Decorated Plasmonic Beads. , 2015, ACS applied materials & interfaces.

[148]  S. Asher,et al.  Dihedral psi angle dependence of the amide III vibration: a uniquely sensitive UV resonance Raman secondary structural probe. , 2001, Journal of the American Chemical Society.

[149]  N. Isaacs,et al.  Raman optical activity and circular dichroism reveal dramatic differences in the influence of divalent copper and manganese ions on prion protein folding. , 2008, Biochemistry.

[150]  R J Fletterick,et al.  Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[151]  Inhee Choi,et al.  Ultra-sensitive, label-free probing of the conformational characteristics of amyloid beta aggregates with a SERS active nanofluidic device , 2012 .

[152]  C. Roberts,et al.  Investigations of the supramolecular structure of individual diphenylalanine nano- and microtubes by polarized Raman microspectroscopy. , 2012, Biomacromolecules.

[153]  A. Shen,et al.  Detection of Alzheimer's disease by Raman spectra of rat's platelet with a simple feature selection , 2013 .

[154]  T. He,et al.  Surface enhanced Raman scattering-active worm-like Ag clusters for sensitive and selective detection of dopamine , 2015 .

[155]  J. Weuve,et al.  Alzheimer disease in the United States (2010–2050) estimated using the 2010 census , 2013, Neurology.

[156]  R. Zbořil,et al.  Magnetically assisted surface-enhanced raman scattering selective determination of dopamine in an artificial cerebrospinal fluid and a mouse striatum using Fe(3)O(4)/Ag nanocomposite. , 2014, Analytical chemistry.